FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q46536361> ?p ?o ?g. }

• Q46536361 description "2005 nî lūn-bûn" @default.
• Q46536361 description "2005年の論文" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年学术文章" @default.
• Q46536361 description "2005年學術文章" @default.
• Q46536361 description "2005年學術文章" @default.
• Q46536361 description "2005年學術文章" @default.
• Q46536361 description "2005年學術文章" @default.
• Q46536361 description "2005年學術文章" @default.
• Q46536361 description "2005년 논문" @default.
• Q46536361 description "article científic" @default.
• Q46536361 description "article scientific" @default.
• Q46536361 description "article scientifique" @default.
• Q46536361 description "articol științific" @default.
• Q46536361 description "articolo scientifico" @default.
• Q46536361 description "artigo científico" @default.
• Q46536361 description "artigo científico" @default.
• Q46536361 description "artigo científico" @default.
• Q46536361 description "artikel ilmiah" @default.
• Q46536361 description "artikull shkencor" @default.
• Q46536361 description "artikulong pang-agham" @default.
• Q46536361 description "artykuł naukowy" @default.
• Q46536361 description "artículo científico publicado en 2005" @default.
• Q46536361 description "artículu científicu" @default.
• Q46536361 description "bilimsel makale" @default.
• Q46536361 description "bài báo khoa học" @default.
• Q46536361 description "naučni članak" @default.
• Q46536361 description "scienca artikolo" @default.
• Q46536361 description "scientific article published in January 2005" @default.
• Q46536361 description "scientific article published in January 2005" @default.
• Q46536361 description "scientific article published in January 2005" @default.
• Q46536361 description "teaduslik artikkel" @default.
• Q46536361 description "tieteellinen artikkeli" @default.
• Q46536361 description "tudományos cikk" @default.
• Q46536361 description "vedecký článok" @default.
• Q46536361 description "vetenskaplig artikel" @default.
• Q46536361 description "videnskabelig artikel" @default.
• Q46536361 description "vitenskapelig artikkel" @default.
• Q46536361 description "vitskapeleg artikkel" @default.
• Q46536361 description "vědecký článek" @default.
• Q46536361 description "wetenschappelijk artikel" @default.
• Q46536361 description "wissenschaftlicher Artikel" @default.
• Q46536361 description "επιστημονικό άρθρο" @default.
• Q46536361 description "мақолаи илмӣ" @default.
• Q46536361 description "наукова стаття, опублікована в січні 2005" @default.
• Q46536361 description "научна статия" @default.
• Q46536361 description "научная статья" @default.
• Q46536361 description "научни чланак" @default.
• Q46536361 description "научни чланак" @default.
• Q46536361 description "מאמר מדעי" @default.
• Q46536361 description "مقالة علمية نشرت في يناير 2005" @default.
• Q46536361 description "জানুয়ারি ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q46536361 description "บทความทางวิทยาศาสตร์" @default.
• Q46536361 description "სამეცნიერო სტატია" @default.
• Q46536361 name "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 name "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 type Item @default.
• Q46536361 label "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 label "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 prefLabel "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 prefLabel "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 P1433 Q46536361-D4D22164-068D-4FE6-AB96-C99B5687EC4E @default.
• Q46536361 P1476 Q46536361-D34D5D0C-09C3-4100-A575-79A484FF4230 @default.
• Q46536361 P2093 Q46536361-11574D8F-842E-42AB-AF92-E23B03E6C599 @default.
• Q46536361 P2093 Q46536361-1BC3AD6F-9890-4885-89C4-B0D385DA8996 @default.
• Q46536361 P2093 Q46536361-3611C769-6753-4036-B7EF-6A17C242F486 @default.
• Q46536361 P2093 Q46536361-44644A58-94EE-4E51-B9E6-970876501972 @default.
• Q46536361 P2093 Q46536361-502B87B9-E802-46C2-BD9B-FCA406354950 @default.
• Q46536361 P2093 Q46536361-5293AB88-BACE-482A-9869-158D913919B4 @default.
• Q46536361 P2093 Q46536361-549A93FB-4DF3-4704-80F3-7EEB58CE9216 @default.
• Q46536361 P2093 Q46536361-7F763197-9168-40B3-9E15-BE2E25F49312 @default.
• Q46536361 P2093 Q46536361-8739FA48-FC15-454E-976D-7BC905A6D248 @default.
• Q46536361 P2093 Q46536361-88146355-291F-4FA7-8D74-DE5B1C576F8F @default.
• Q46536361 P2093 Q46536361-956B5817-12D1-4375-B723-E59B8825041D @default.
• Q46536361 P2860 Q46536361-0EA10DEE-864B-45AD-B300-436D4E0D9E34 @default.
• Q46536361 P2860 Q46536361-1FA3568F-42BC-4782-9C04-C482BBF67C45 @default.
• Q46536361 P2860 Q46536361-5AE119A8-E25F-4C8A-8EA8-85A7827B78FA @default.
• Q46536361 P2860 Q46536361-829D2702-D2A0-4F8B-A97A-3DCDFB62E76A @default.
• Q46536361 P2860 Q46536361-93928D6F-F89D-444A-BA02-1F613714F797 @default.
• Q46536361 P2860 Q46536361-AE94C582-BE8C-4D33-97F8-316FF970D496 @default.
• Q46536361 P304 Q46536361-66CC11B4-E02B-43B4-9F18-BCD251A7C075 @default.
• Q46536361 P31 Q46536361-E194073D-D35A-490C-9A2F-80EF12709797 @default.
• Q46536361 P356 Q46536361-F3BD113A-3B90-47CF-AEC0-C2C95CDC9081 @default.
• Q46536361 P433 Q46536361-B2A7D9CA-BA18-41CC-8B15-89C666206890 @default.
• Q46536361 P478 Q46536361-DBAD65B3-101C-4F46-82AE-FED5251BFDD2 @default.
• Q46536361 P50 Q46536361-8C212BB6-9D66-4DCD-8CEA-D2D7B3AB7B90 @default.
• Q46536361 P577 Q46536361-8B12E638-0520-4B00-8471-501CA016C5A0 @default.
• Q46536361 P698 Q46536361-8B11CBBD-2E14-49E0-846D-744B4F1F9658 @default.
• Q46536361 P921 Q46536361-20FAC661-45AB-4593-9D0D-B884729F4CAE @default.
• Q46536361 P921 Q46536361-3A654C49-AC50-4106-8710-5C059325116F @default.
• Q46536361 P356 CNV-200055956 @default.
• Q46536361 P698 15945507 @default.
• Q46536361 P1433 Q325953 @default.
• Q46536361 P1476 "A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer" @default.
• Q46536361 P2093 "Aziz Karaoglu" @default.
• Q46536361 P2093 "Demirali Onat" @default.

• next